If you plan to in-license assets, Vault creates or works within existing Portfolio Strategies to identify areas of opportunity and partners with you to assess the value, strategic fit and potential risks of acquiring the particular target molecule, providing perspectives within the context of future competitive challenges and evolving treatment paradigms.

For your out-license asset initiatives, we perform a deep assessment of available data using clinical, regulatory and commercial strategies to develop a competitive market analysis, propose product development and commercialization strategies to help maximize asset value, identify potential buyers, create the presentation strategy and materials, and provide you support in the negotiation process.

We perform complete landscape assessments to identify investment and licensing opportunities on the buy and sell side. Vault’s team possesses the unique capability to conduct both scientific and commercial evaluation, sequentially or in parallel, assuring the clinical and commercial paths to value creation provide you accurate data for decision-making and a quantifiable returns on investment.

Vault applies consistent, multi-functional perspectives throughout the evaluation and due diligence process to provide you with insights for functional or integrated value creation.

We assist in your business development activities, providing expertise in identifying partners and bridging interested parties to explore opportunities.

Vault Bioventures creates, uncovers, & captures the value of your biopharmaceutical assets through marketplace adoption, investment decisions and operational execution.

By harnessing the power of integration, we align and facilitate your key organizational strategic and operational levers to deliver value driven solutions and break-through business performance.

Our team guides you through stakeholder ecosystems by analyzing complex infrastructures, evaluating organizational patterns, & providing detailed, unrealized roadmaps.